首页> 外国专利> Heterocyclic piperidine or tetrahydropyridine derivatives or a pharmaceutically acceptable salt thereof or its hydrate, antagonist against crf receptors, and use of a heterocyclic tetrahydropyridine derivative or a pharmaceutically acceptable salt thereof or its hydrate

Heterocyclic piperidine or tetrahydropyridine derivatives or a pharmaceutically acceptable salt thereof or its hydrate, antagonist against crf receptors, and use of a heterocyclic tetrahydropyridine derivative or a pharmaceutically acceptable salt thereof or its hydrate

机译:杂环哌啶或四氢吡啶衍生物或其药学上可接受的盐或其水合物,抗crf受体的拮抗剂,以及杂环四氢吡啶衍生物或其药学上可接受的盐或其水合物的用途

摘要

"HYPEROCYCICAL DERIVATIVES OF PIPERIDINE OR TETRAIDROPYRIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME OR ITS HYDRATE, ANTAGONIST AGAINST CRF RECEIVERS, AND USE OF A HETEROCYCLE DERIVATIVE OF THE TETRAHYDROPETHYDROPYRIDINE A piperidine or tetrahydropyridine derivative represented by formula (I): A-Het [1] has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.
机译:“哌啶或叔丁基吡啶或该化合物或其水合物的药学可接受的盐,抗CRF受体的拮抗剂的高环衍生物,以及使用由四氢哌啶四环哌啶衍生物(四氢吡啶基吡啶)衍生的杂环衍生物:对CRF受体具有高亲和力,并且对被认为与CRF有关的疾病有效。

著录项

  • 公开/公告号BR0112166A

    专利类型

  • 公开/公告日2003-09-02

    原文格式PDF

  • 申请/专利权人 TAISHO PHARMACEUTICAL CO. LTD.;

    申请/专利号BR20010112166

  • 申请日2001-07-04

  • 分类号C07D401/04;C07D401/14;C07D417/04;C07D471/04;C07D487/04;C07D495/04;C07D498/04;C07D513/04;A61K31/4365;A61K31/4439;A61K31/4709;A61K31/4725;A61K31/506;A61K31/517;A61K31/519;A61K31/53;A61K31/5377;A61P43/00;A61P9/00;

  • 国家 BR

  • 入库时间 2022-08-22 00:03:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号